Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy

• Status: Completed
• Trial end date: 2018-01-05
• Target enrollment: 0
• Participant gender: All

Summary

The efficacy of oral dexmedetomidine as sedative versus a combination of oral midazolam plus oral ketamine were compared regarding to satisfactory separation from parents, satisfactory mask induction and postoperative rescue analgesia in Pediatrics undergone Adenotosillectomy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Suez Canal University
• Treatments: Dexmedetomidine; Ketamine; Midazolam

Criteria

Inclusion Criteria:

• Children with ASA I (American Society of Anesthesiologists physical status Grade I) = (normal healthy patients) or ASA II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations)

• Children scheduled for adenotonsillectomy

Exclusion Criteria:

• Children with central nervous system disorders & neurological problems.

• Children with inborn errors of metabolism.

• Obese children (BMI >30 kg/m2).

• Children with known allergy to dexmedetomidine, midazolam or ketamine.

• Children who vomit.

• Children with recent or chronic administration of sedative drugs, antipsychotics or tranquilizers.